Related Experiment Video
Updated: Jul 16, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Suppression of beta cell energy metabolism and insulin release by PGC-1alpha
J Cliff Yoon1, Gang Xu, Jude T Deeney
1Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.
Abstract:
beta cell dysfunction is an important component of type 2 diabetes, but the molecular basis for this defect is poorly understood. The transcriptional coactivator PGC-1alpha mRNA and protein levels are significantly elevated in islets from multiple animal models of diabetes; adenovirus-mediated expression of PGC-1alpha to levels similar to those present in diabetic rodents produces a marked inhibition of glucose-stimulated insulin secretion from islets in culture and in live mice. This inhibition coincides with changes in metabolic gene expression associated with impaired beta cell function, including the induction of glucose-6-phosphatase and suppression of GLUT2, glucokinase, and glycerol-3-phosphate dehydrogenase. These changes result in blunting of the glucose-induced rise in cellular ATP levels and membrane electrical activity responsible for Ca(2+) influx and insulin exocytosis. These results strongly suggest that PGC-1alpha plays a key functional role in the beta cell and is involved in the pathogenesis of the diabetic phenotype.
Insights
Elevated PGC-1alpha in pancreatic beta cells impairs insulin secretion, contributing to type 2 diabetes. This molecular defect affects glucose metabolism and insulin release, highlighting PGC-1alpha
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Diseases
Background:
- Beta cell dysfunction is a key factor in type 2 diabetes pathogenesis.
- The precise molecular mechanisms underlying beta cell dysfunction remain largely unknown.
Purpose of the Study:
- To investigate the role of the transcriptional coactivator PGC-1alpha in beta cell function and its potential contribution to type 2 diabetes.
Main Methods:
- Examined PGC-1alpha mRNA and protein levels in islets from diabetic animal models.
- Utilized adenovirus-mediated expression of PGC-1alpha in isolated islets and live mice.
- Analyzed changes in metabolic gene expression and insulin secretion.
Main Results:
- PGC-1alpha levels were significantly elevated in islets of diabetic animal models.
- Overexpression of PGC-1alpha inhibited glucose-stimulated insulin secretion.
- Observed altered expression of key metabolic genes, including glucose-6-phosphatase, GLUT2, glucokinase, and glycerol-3-phosphate dehydrogenase.
- Demonstrated blunted glucose-induced ATP production and impaired calcium influx, leading to reduced insulin exocytosis.
Conclusions:
- PGC-1alpha plays a critical functional role in pancreatic beta cells.
- Elevated PGC-1alpha is implicated in the pathogenesis of the diabetic phenotype by disrupting normal beta cell function and insulin secretion.
Related Concept Videos
Cell Specific Gene Expression
GPCRs Regulate Adenylyl Cylase Activity
Two...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon
Type II Diabetes II: Pathophysiology

